SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Proposed Listing

4 Sep 2007 07:02

Accsys Technologies PLC04 September 2007 4th September 2007 AIM: AXS ACCSYS LAUNCHES OFFERING AND EURONEXT AMSTERDAM LISTING Accsys Technologies PLC (''Accsys'') announces the proposed listing of itsordinary shares on Euronext Amsterdam by NYSE Euronext and a public offering inThe Netherlands and private placement to certain institutional investors outsideThe Netherlands of ordinary shares (the ''Offering''), following its earlierannouncements on 20th August 2007 and 28th June 2007. The Offering consists ofup to 5 million new ordinary shares offered by Accsys and up to 10 millionexisting ordinary shares offered by certain existing shareholders (the ''Shares''). Accsys has applied for all ordinary shares to be listed and admittedto trading on Euronext Amsterdam by NYSE Euronext (the ''Euronext Listing'')under the symbol 'AXS'. Accsys will also apply for admission of the new ordinaryshares being issued pursuant to the Offering to trading on AIM. Offering information • The Offering, in respect of which Fortis Bank (Nederland) N.V. ("Fortis") is the lead manager and sole bookrunner) includes an offering of up to 5 million new ordinary shares offered by Accsys and up to 10 million existing ordinary shares offered by certain existing shareholders, potentially complemented with an over-allotment granted by Accsys to Fortis in respect of new ordinary shares up to a maximum amount of 15% of the number of Shares offered, subject to the consent of Accsys. • The offer price and the actual number of Shares offered in the Offering will be determined on the basis of a bookbuilding process taking into account, inter alia, the share price of Accsys' ordinary shares as quoted on AIM prior to the pricing date and a qualitative assessment of demand for the Shares. • The subscription period will commence on 4th September 2007 and will end on 17th September 2007. • Pricing is expected to take place subsequent to the subscription period, prior to the listing of all of Accsys' ordinary shares on Euronext Amsterdam by NYSE Euronext. • The Euronext Listing is expected to take place on or about 18 September 2007. • Application will also be made for the new ordinary shares being issued pursuant to the Offering to be admitted to trading on AIM. • A prospectus has been prepared by Accsys in connection with the Offering and the Euronext Listing and contains updated information on the Accsys and its subsidiaries (the "Group") and their respective businesses (including an updated profit forecast for the Group for the financial year ending 31 March 2008). • The prospectus has been approved by the UKLA and will be made available through advertisements in the Daily Official List (Officiele Prijscourant) and in a Dutch national newspaper (Het Financieele Dagblad). Hard copies of this prospectus and any subsequent supplement to this prospectus, may be obtained at no cost at either of the following addresses: • Accsys (66 Hammersmith Road, London W14 8UD, United Kingdom). • Fortis (Rokin 55, 1012 KK Amsterdam, tel: +31 20 527 2467, email: prospectus@nl.fortis.com). Alternatively, the prospectus may be obtained in electronic form through thewebsite of Accsys at www.accsysplc.com/investor_governance or (in the case ofDutch residents only) through the website of NYSE Euronext at www.euronext.com . • Accsys intends to allocate the majority of the net proceeds from the issue of new ordinary shares as follows: • to double the capacity of the Arnhem manufacturing facilities; • to increase warehousing, storage and office facilities in Arnhem; • to create post acetylation finishing capability, including finger-jointing and lamination; • to advance the wood fibre technology for panel products to a commercial scale; • to increase licensing activity and support, increasing staffing levels; • to increase brand and product marketing and exploring additional product applications; • to maximise the potential of AccoyaTM by exploring and developing additional product applications including, for example, civil and structural uses; and • to allow for strategic investments where appropriate. Accsys however, will retain broad discretion over the allocation of the netproceeds • The distribution of the prospectus, and the offer and sale of the Shares may be restricted by law in certain jurisdictions. Persons in possession of the prospectus are required to inform themselves about and to observe any such restrictions. Each prospective investor should consult his or her own professional advisor(s) before deciding to make any investment decision concerning the Shares and in order to determine whether or not such prospective investor is lawfully permitted to purchase the ordinary Shares. Prospective investors have to base their opinion on the prospectus. Willy Paterson-Brown, CEO Accsys commented: 'The listing on Euronext Amsterdamand the Offering are very important steps for Accsys for a number of reasons. Weanticipate that shareholder value may be improved by listing on a regulatedmarket; liquidity in the shares may be improved by additional market coverage;various potential investors will now be able to take a position due to thesenior market nature of NYSE Euronext; and with the operations of Accsys beingin The Netherlands, there is a strong Dutch focus to the business. we arelooking forward to being listed on Euronext Amsterdam by NYSE Euronext andexcited about taking the Company to its next stage of development'. Fortis has been appointed Sole Lead Manager and Bookrunner for the Offering. For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8144 2510 Chairman & CEO Parkgreen Communications Justine Howarth +44 (0) 20 7851 7480 Citigate First Financial B.V Jose Tijssen +31 (0)20 575 4024 Frank Jansen Information on the Accsys Group of Companies: Accsys Technologies PLC (www.accsysplc.com) - is an environmental science andtechnology company whose primary focus is on the production and licensing ofAccoyaTM via its 100% owned subsidiary, Titan Wood (www.titanwood.com), withmanufacturing operations based in Arnhem, The Netherlands. AccoyaTM,manufactured through the Company's proprietary acetylation process, exhibitssuperior dimensional stability and durability compared with other natural andtreated timber. Accsys is also developing technology to modify wood fibre toenable future production of a range of panel products. Accsys' operations comprise three principal business units: (i) the AccoyaTMproduction facility located in Arnhem, The Netherlands; (ii) technologydevelopment focused on a programme of continuous improvements to the processengineering and operating protocols for the acetylation of wood which arecurrently under development as well as the development of technology for theacetylation of wood fibre; and (iii) the licensing of technology for theproduction of AccoyaTM across the globe. Accsys' ordinary shares are traded on the London Stock Exchange AIM market underthe symbol 'AXS'. As of the closing price of Accsys shares on AIM on 3 September2007, the Company has a market capitalisation of EUR 625m. Please be referred toAccsys' website at www.accsysplc.com for the company's latest financial report. AccoyaTM wood (www.accoya.info) is produced using acetylation processes whichare broadly based on patented technology and supported by complex operationalknow-how, that effectively converts sustainably grown softwoods and non-durablehardwoods into what is best described as a 'new wood species'. Distinguished byits durability, dimensional stability and, perhaps most importantly, itsreliability (in terms of consistency of both supply and quality), AccoyaTM woodis particularly suited to exterior applications where performance and appearanceare valued. Unlike most tropical and European hardwoods, its colour does notdegrade when exposed to ultraviolet light. Moreover, the AccoyaTM woodproduction process does not compromise the wood's strength or machinability. Thecombination of UV resistance, dimensional stability, durability and retainedstrength means that AccoyaTM wood offers a wealth of new opportunities toarchitects, designers and specifiers. For marine uses where weight is alsoimportant, AccoyaTM wood for the first time provides boat builders with a woodthat is strong and durable, which retains its natural beauty for far longer,without a dramatic weight increase. ACCOYA is a registered trademark owned by Titan Wood Limited Other information: Not for release, distribution or publication into or in the United States,Australia, Canada or Japan. This announcement is not an offer to sell or a solicitation of any offer to buythe securities of Accsys Technologies PLC (the "Company", and such securities,the "Securities") in the United States or in any other jurisdiction. The Securities have not been and will not be registered under the U.S.Securities Act of 1933, as amended (the "Securities Act") and may not be offeredor sold in the United States unless registered under the Securities Act or anexemption from such registration is available. No public offering of Securitiesof the Company is being made in the United States. This announcement does not constitute a prospectus. The offer to acquireSecurities pursuant to the proposed offering will be made, and any investorshould make his investment, solely on the basis of information that will becontained in the prospectus to be made generally available in The Netherlands inconnection with such offering. When made generally available, copies of theprospectus may be obtained at no cost through the website of Euronext Amsterdam(Dutch residents only) and the website of the Company. All investment is subject to risk. The value of the Securities offered may godown as well as up. Past performance is no guarantee of future returns.Potential investors are advised to seek expert financial advice before makingany investment decision. In connection with the offering, Fortis Bank (Nederland) N.V. (the "Stabilisation Manager") (or persons acting on behalf of the StabilisationManager) may over-allot shares or effect transactions with a view to supportingthe market price of the Securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilisation Manager(or persons acting on behalf of the Stabilisation Manager) will undertakestabilisation action. Any stabilisation action may begin on or after the date onwhich adequate public disclosure of the final offer price of the Securities ismade and, if begun, may be ended at any time, but it must end no later than 30days after allotment of the Securities. Certain statements in this announcement are forward-looking statements. Theseforward-looking statements speak only as at the date of this announcement. Suchstatements are based on current expectations and beliefs and, by their nature,are subject to a number of known and unknown risks and uncertainties that couldcause actual results and performance to differ materially from any expectedfuture results or performance expressed or implied by the forward-lookingstatement. The information and opinions expressed in this announcement aresubject to change without notice and neither the Company nor Fortis Bank(Nederland) N.V. assumes any responsibility or obligation to update publicly orreview any of the forward-looking statements contained herein, regardless ofwhether those statements are affected by the results of new information, futureevents or otherwise. ENDS This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.